Biogen’s newly approved Alzheimer’s drug Aduhelm has given patients like 69-year-old Bill McKay hope. His doctor Cara Leahy warns that the drug is not a holy grail, though
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en